Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Bone Miner Res ; 31(3): 615-29, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26391310

RESUMEN

Cathepsin K (CK), a lysosomal cysteine protease, is highly expressed in mature osteoclasts and degrades type 1 collagen. Odanacatib (ODN) is a selective and reversible CK inhibitor that inhibits bone loss in preclinical and clinical studies. Although an antiresorptive, ODN does not suppress bone formation, which led us to hypothesize that ODN may display restorative effect on the osteopenic bones. In a curative study, skeletally mature New Zealand rabbits were ovarectomized (OVX) and after induction of bone loss were given a steady-state exposure of ODN (9 mM/d) for 14 weeks. Sham-operated and OVX rabbits treated with alendronate (ALD), 17b-estradiol (E2), or parathyroid hormone (PTH) served as various controls. Efficacy was evaluated by assessing bone mineral density (BMD), bone microarchitecture (using micro-computed tomography), fluorescent labeling of bone, and biomechanical strength. Skeletal Ca/P ratio was measured by scanning electron microscopy (SEM) with X-ray microanalysis, crystallinity by X-ray diffraction, and bone mineral density distribution (tissue mineralization) by backscattered SEM. Between the sham and ODN-treated osteopenic groups, lumbar and femur metaphyseal BMD, Ca/P ratio, trabecular microstructure and geometric indices, vertebral compressive strength, trabecular lining cells, cortical parameters (femoral area and thickness and periosteal deposition), and serum P1NP were largely comparable. Skeletal improvements in ALD-treated or E2-treated groups fell significantly short of the sham/ODN/PTH group. However, the ODN group displayed reduced ductility and enhanced brittleness of central femur, which might have been contributed by higher crytallinity and tissue mineralization. Rabbit bone marrow stromal cells expressed CK and when treated with ODN displayed increased formation of mineralized nodules and decreased apoptosis in serum-deficient medium compared with control. In vivo, ODN did not suppress remodeling but inhibited osteoclast activity more than ALD. Taken together, we show that ODN reverses BMD, skeletal architecture, and compressive strength in osteopenic rabbits; however, it increases crystallinity and tissue mineralization, thus leading to increased cortical bone brittleness.


Asunto(s)
Alendronato/uso terapéutico , Compuestos de Bifenilo/uso terapéutico , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Hueso Esponjoso/patología , Hueso Cortical/patología , Drogas en Investigación/uso terapéutico , Estrógenos/uso terapéutico , Hormona Paratiroidea/uso terapéutico , Alendronato/farmacología , Animales , Fenómenos Biomecánicos/efectos de los fármacos , Compuestos de Bifenilo/farmacología , Densidad Ósea/efectos de los fármacos , Enfermedades Óseas Metabólicas/patología , Enfermedades Óseas Metabólicas/fisiopatología , Calcificación Fisiológica/efectos de los fármacos , Hueso Esponjoso/efectos de los fármacos , Hueso Esponjoso/fisiopatología , Hueso Cortical/efectos de los fármacos , Hueso Cortical/fisiopatología , Cristalización , Diáfisis/efectos de los fármacos , Diáfisis/patología , Diáfisis/fisiopatología , Drogas en Investigación/farmacología , Estrógenos/farmacología , Femenino , Fémur/efectos de los fármacos , Fémur/patología , Fémur/fisiopatología , Vértebras Lumbares/efectos de los fármacos , Vértebras Lumbares/patología , Vértebras Lumbares/fisiopatología , Osteoblastos/efectos de los fármacos , Osteoblastos/patología , Osteoclastos/efectos de los fármacos , Osteoclastos/patología , Osteoporosis/patología , Osteoporosis/fisiopatología , Hormona Paratiroidea/farmacología , Conejos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA